4.6 Article

Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals

期刊

ADDICTION
卷 111, 期 4, 页码 685-694

出版社

WILEY
DOI: 10.1111/add.13214

关键词

Drug users; harm reduction; health services; hospitals; patient-centered care; qualitative

资金

  1. NIDA NIH HHS [R01 DA033147, U01 DA038886] Funding Source: Medline

向作者/读者索取更多资源

AimsTo explore the perspectives of structurally vulnerable people who use drugs (PWUD) regarding: (1) the potential integration of harm reduction interventions (e.g. supervised drug consumption services, opioid-assisted treatment) into hospitals; and (2) the implications of these interventions for patient-centered care, hospital outcomes and drug-related risks and harms. DesignSemi-structured qualitative interviews. SettingVancouver, Canada. ParticipantsThirty structurally vulnerable PWUD who had been discharged from hospital against medical advice within the past 2years, and hospitalized multiple times over the past 5years. MeasurementsSemi-structured interview guide including questions to elicit perspectives on hospital-based harm reduction interventions. FindingsParticipant accounts highlighted that hospital-based harm reduction interventions would promote patient-centered care by: (1) prioritizing hospital care access and risk reduction over the enforcement of abstinence-based drug policies; (2) increasing responsiveness to subjective health needs (e.g. pain and withdrawal symptoms); and (3) fostering culturally safe' care. ConclusionsHospital-based harm reduction interventions for people who use drugs, such as supervised drug consumption services and opioid-assisted treatment, can potentially improve hospital care retention, promote patient-centered care and reduce adverse health outcomes among people who use drugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据